Sort   by:  
 Page size 
GenomicsMS
WTCCC1 project Multiple Sclerosis (MS) samples
EGAD00000000012 | EGA
GenomicsWTCCC case-control study for Multiple Sclerosis - Combined controls
WTCCC genome-wide accosication study for Multiple Sclerosis (MS) - Combined controls
EGAS00000000023 | EGA
GenomicsWTCCC case-control study for Multiple Sclerosis
WTCCC genome-wide case-control association study for Multiple Sclerosis (MS) using the 1958 British Birth Cohort collection as controls.
EGAS00000000022 | EGA
ProteomicsSurface and global proteome profiling of osteosarcoma patient derived xenografts
This study analyzed 22 unique OS patient-derived xenografts (PDXs) using proteomics to identify surface proteins for potential immunotherapeutic targeting. Plasma membranes were enriched using density gradient ultracentrifugation and compared to a reference standard of 12 immortalized non-OS cell li...
ORGANISM(S): Homo sapiens (Human) 
2026-07-28 | PXD075484 | Pride
Osteosarcoma 
ProteomicsUncovering biological heterogeneity in endometrial carcinoma molecular subtypes by proteomic analysis
While endometrial cancer (EC) has an overall favorable prognosis, some patients do poorly and may benefit from refinements of current classification systems. Molecular classification stratifies ECs into four prognostic groups: POLEmut, MMRd (mismatch repair deficient), p53abn, and NSMP (no specific ...
ORGANISM(S): Homo sapiens (Human) 
2025-10-06 | PXD057700 | Pride
Ffpe Endometrial carcinoma Tmt 
ProteomicsThe CASP3 Prodomain Regulates Human Cell Survival and Proliferation
CASPASE-3 (CASP3) is well known for its proteolytic function that mediates multiple key cell death-initiated processes and other related cellular processes. However, the possibility that CASP3 may also possess important additional non-catalytic functions in mammalian cells has remained largely unexp...
ORGANISM(S): Homo sapiens (Human) 
2024-01-17 | PXD045234 | Pride
Casp3 Mammary cells 
ProteomicsChanges in the tumor microenvironment mark transition from serous borderline tumor to low grade serous carcinoma
Low grade serous ovarian cancer (LGSC) is a rare subtype of ovarian cancer, characterized by a slow growth rate, resistance to current treatment regimens, multiple recurrences and poor survival. LGSC arise from serous borderline tumor (SBT), however the mechanism of transformation is poorly understo...
ORGANISM(S): Homo sapiens (Human) 
2024-08-15 | PXD046360 | Pride
Tmt Ovarian cancer Serous borderline tumor 
ProteomicsProteomic analysis of archival breast cancer clinical specimens identifies biological subtypes with distinct survival outcomes
Despite the advancement of genomic classification of breast cancer, current clinical tests and treatment decisions are commonly based on protein level information. Formalin-fixed paraffin-embedded (FFPE) tissue specimens are widely available and can be directly linked to extended clinical outcomes. ...
ORGANISM(S): Homo sapiens (Human) 
2022-02-22 | PXD024322 | Pride
Proteomics Tmt Ffpe Breast cancer 
GenomicsIdentification of Transcription Factor SKN-1::GFP Binding Regions in L1
modENCODE_submission_2622 This submission comes from a modENCODE project of Michael Snyder. For full list of modENCODE projects, see http://www.genome.gov/26524648 Project Goal: We are identifying the DNA binding sites for 300 transcription factors in C. elegans. Each transcription factor gene is ta...
ORGANISM(S): Caenorhabditis elegans 
2011-02-18 | E-GEOD-25810 | biostudies-arrayexpress
ProteomicsGlobal proteome analysis of shROR2 MNNG cells
MNNG cells expressing a doxycycline (DOX)-inducible non-targeting shRNA (shCTRL) construct, or three independent shRNA constructs targeting ROR2 (shROR2 1, shROR2 2 and shROR2 3), were grown for 7 days in the presence of 5 µg/ml DOX prior to extraction.
ORGANISM(S): Homo sapiens (Human) 
2026-07-28 | PXD077022 | Pride
Ror2 Osteosarcoma 
Sort   by:  
 Page size